PMC:7796072 / 13636-13849
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"361","span":{"begin":116,"end":119},"obj":"Gene"}],"attributes":[{"id":"A361","pred":"tao:has_database_id","subj":"361","obj":"Gene:3046"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The frequency of the O blood group in Thailand is 40.5% [59] and its relatively high prevalence along with the high HbE heterozygote frequency could further potentiate the hypothesized antiviral protective effect."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T87","span":{"begin":0,"end":213},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The frequency of the O blood group in Thailand is 40.5% [59] and its relatively high prevalence along with the high HbE heterozygote frequency could further potentiate the hypothesized antiviral protective effect."}